| Expression pattern: |
DN |
| Associated gene: |
- |
| Associated microRNA: |
hsa-miR-145, hsa-miR-1282, hsa-miR-326, hsa-miR-558, hsa-miR-330-5p |
| Biological function: |
inhibits proliferation; inhibits migration; inhibits invasion (tumor suppressor effect) in bladder cancer cells |
| Molecular mechanism: |
Predicted ceRNA network (circRNA-miRNA-mRNA); downstream miRNAs and proteins were not experimentally validated. |
| Biological pathway or process: |
ceRNA regulation (other); proliferation (inhibits); migration (inhibits); invasion (inhibits) |
| Detected method: |
Q
S
|
| Validation methods: |
RNA-seq; RT-qPCR; RNase R Treatment; Clinical Sample Validation; CCK8; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Survival Analysis; ROC Analysis; Bioinformatics Analysis; Transfection |
| Clinical significance: |
Lower expression is associated with worse clinicopathological features; diagnostic value (ROC AUC 0.790); low expression correlates with shorter OS and RFS; independent prognostic factor. |
| Description: |
hsa_circ_0004826 is significantly down-regulated in bladder cancer and functions as a tumor suppressor, as its overexpression inhibits proliferation, migration, and invasion of BC cells. Clinically, low expression is associated with aggressive features and poorer survival, and it shows diagnostic potential by ROC analysis. It is included in a bioinformatically predicted circRNA-miRNA-mRNA (ceRNA) network, but downstream targets were not validated experimentally. |
| Confidence score: |
0.7617 |